149 related articles for article (PubMed ID: 36604211)
1. Lung shunt fraction calculations before Y-90 transarterial radioembolization: Comparison of accuracy and clinical significance of planar scintigraphy and SPECT/CT.
Young S; Flanagan S; D'Souza D; Todatry S; Ragulojan R; Sanghvi T; Golzarian J
Diagn Interv Imaging; 2023 Apr; 104(4):185-191. PubMed ID: 36604211
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?
Elsayed M; Cheng B; Xing M; Sethi I; Brandon D; Schuster DM; Bercu Z; Galt J; Barron B; Kokabi N
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):254-260. PubMed ID: 33000319
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic
Struycken L; Patel M; Kuo P; Hennemeyer C; Woodhead G; McGregor H
AJR Am J Roentgenol; 2022 Apr; 218(4):728-737. PubMed ID: 34704460
[No Abstract] [Full Text] [Related]
4. Factors modulating
Lopez BP; Mahvash A; Long JP; Lam MGEH; Kappadath SC
J Appl Clin Med Phys; 2022 Dec; 23(12):e13734. PubMed ID: 35906892
[TBL] [Abstract][Full Text] [Related]
5. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
6. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
[TBL] [Abstract][Full Text] [Related]
7. Measurement of the Tumor-to-Normal Ratio for Radioembolization of Hepatocellular Carcinoma: A Prospective Study Comparing 2-Dimensional Perfusion Angiography, Technetium-99m Macroaggregated Albumin, and Yttrium-90 SPECT/CT.
Brunson CP; McGregor HJ; Hennemeyer CT; Patel MV; Woodhead GJ; Young SJ
J Vasc Interv Radiol; 2024 Jan; 35(1):94-101. PubMed ID: 37783268
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of imaging
Kunnen B; Dietze MMA; Braat AJAT; Lam MGEH; Viergever MA; de Jong HWAM
Med Phys; 2020 Mar; 47(3):1105-1114. PubMed ID: 31855282
[TBL] [Abstract][Full Text] [Related]
9. Calculation of lung mean dose and quantification of error for
Lopez B; Mahvash A; Lam MGEH; Kappadath SC
Med Phys; 2019 Sep; 46(9):3929-3940. PubMed ID: 31063600
[TBL] [Abstract][Full Text] [Related]
10. High quality imaging and dosimetry for yttrium-90 (
Duan H; Khalaf MH; Ferri V; Baratto L; Srinivas SM; Sze DY; Iagaru A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2426-2436. PubMed ID: 33443618
[TBL] [Abstract][Full Text] [Related]
11. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS
J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
[TBL] [Abstract][Full Text] [Related]
12. Outpatient single-session yttrium-90 glass microsphere radioembolization.
Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
[TBL] [Abstract][Full Text] [Related]
13. CT texture features and lung shunt fraction measured using
Lee JH; Lee CH; Kim M; Song YS; Yoon CJ; Lee WW
Sci Rep; 2023 Dec; 13(1):22288. PubMed ID: 38097801
[TBL] [Abstract][Full Text] [Related]
14. Radioembolization lung shunt estimation based on a
Kunnen B; van der Velden S; Bastiaannet R; Lam MGEH; Viergever MA; de Jong HWAM
Med Phys; 2018 Oct; 45(10):4744-4753. PubMed ID: 30179259
[TBL] [Abstract][Full Text] [Related]
15. Comparison of perfused volume segmentation between cone-beam CT and
Martin M; Hocquelet A; Debordeaux F; Bordenave L; Blanc JF; Papadopoulos P; Lapuyade B; Trillaud H; Pinaquy JB
Diagn Interv Imaging; 2021 Jan; 102(1):45-52. PubMed ID: 33032960
[TBL] [Abstract][Full Text] [Related]
16. (⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres.
Elschot M; Nijsen JF; Lam MG; Smits ML; Prince JF; Viergever MA; van den Bosch MA; Zonnenberg BA; de Jong HW
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1965-75. PubMed ID: 24819055
[TBL] [Abstract][Full Text] [Related]
17. The value of
Allred JD; Niedbala J; Mikell JK; Owen D; Frey KA; Dewaraja YK
EJNMMI Res; 2018 Jun; 8(1):50. PubMed ID: 29904808
[TBL] [Abstract][Full Text] [Related]
18. Lung dose calculation with SPECT/CT for ⁹⁰Yittrium radioembolization of liver cancer.
Yu N; Srinivas SM; Difilippo FP; Shrikanthan S; Levitin A; McLennan G; Spain J; Xia P; Wilkinson A
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):834-9. PubMed ID: 22871239
[TBL] [Abstract][Full Text] [Related]
19. Repeat Evaluation of Lung Shunt Fraction is Unnecessary: A Retrospective Observational Study of Successive Lung Shunt Fractions from Variable Arterial Distributions in Patients Undergoing Radioembolization of Primary and Secondary Liver Tumors.
Bulman JC; Zurkiya O; Wu V; Wehrenberg-Klee E; Palmer E; Chow D; Brook A; Ganguli S
J Vasc Interv Radiol; 2021 Mar; 32(3):412-418. PubMed ID: 33341340
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
Demirelli S; Erkilic M; Oner AO; Budak ES; Gunduz S; Ozgur O; Bozcuk H; Sindel HT; Boz A
Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]